![Anthony Parker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 154 924 $ in data 31/07/2026
Anthony Michael Parker is the founder of Beagle Partners LLP, founded in 2004, where he holds the title of Partner.
He is also the founder of Argonaute RNA Ltd., founded in 2015, where he holds the title of Chairman.
Currently, Mr. Parker is a Non-Executive Director at Allergy Therapeutics Plc.
He is also a Director at Bristol Bluegreen Ltd., Cbderma Technology Ltd., Inverpharma Ltd., Las Lilas Ltd., and Rosemont Wildwall Ltd.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 30/06/2025 | 1.925.000 ( 0,03% ) | 154 924 $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ALLERGY THERAPEUTICS PLC | Direttore/Membro del Consiglio | 06/12/2022 |
Beagle Partners LLP
 Beagle Partners LLP Investment ManagersFinance Beagle Partners specializes in investments with high capital growth potential. They are active in identifying companies with growth businesses both within Emerging Industries and Emerging Markets. The firm is also active providing investment advice in special situations, helping strategic investors with management engagement and executing strategies for active shareholder involvement. | Amministratore Delegato | 01/01/2004 |
Argonaute RNA Ltd.
 Argonaute RNA Ltd. Miscellaneous Commercial ServicesCommercial Services Develops safe and reliable methods of temporarily silencing target genes in different tissue cells | Fondatore | 01/01/2015 |
Bristol Bluegreen Ltd.
 Bristol Bluegreen Ltd. Electronic Production EquipmentElectronic Technology Develops voltage management and energy conservation products for domestic & commercial use | Direttore/Membro del Consiglio | - |
Cbderma Technology Ltd. | Direttore/Membro del Consiglio | - |
Inverpharma Ltd. | Direttore/Membro del Consiglio | - |
Las Lilas Ltd. | Direttore/Membro del Consiglio | - |
Rosemont Wildwall Ltd. | Direttore/Membro del Consiglio | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 8 |
|---|---|
Allergy Therapeutics Plc
 Allergy Therapeutics Plc Pharmaceuticals: OtherHealth Technology Manufactures subcutaneous and sublingual immunotherapy treatments for a wide range of allergic conditions | Health Technology |
Beagle Partners LLP
Beagle Partners LLP Investment ManagersFinance Beagle Partners specializes in investments with high capital growth potential. They are active in identifying companies with growth businesses both within Emerging Industries and Emerging Markets. The firm is also active providing investment advice in special situations, helping strategic investors with management engagement and executing strategies for active shareholder involvement. | Finance |
Argonaute RNA Ltd.
Argonaute RNA Ltd. Miscellaneous Commercial ServicesCommercial Services Develops safe and reliable methods of temporarily silencing target genes in different tissue cells | Commercial Services |
Bristol Bluegreen Ltd.
Bristol Bluegreen Ltd. Electronic Production EquipmentElectronic Technology Develops voltage management and energy conservation products for domestic & commercial use | Electronic Technology |
Cbderma Technology Ltd. | |
Inverpharma Ltd. | |
Las Lilas Ltd. | |
Rosemont Wildwall Ltd. |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
